Literature DB >> 22042470

Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.

Dario Ribero1, Marco Amisano, Roberto Lo Tesoriere, Stefano Rosso, Alessandro Ferrero, Lorenzo Capussotti.   

Abstract

OBJECTIVE: To assess the survival benefit of additional resection of an intraoperative positive proximal bile duct margin (BD(Marg)) in patients undergoing hepatectomy for hilar cholangiocarcinoma (HCCA). SUMMARY BACKGROUND DATA: Intraoperative evidence of invasive cancer at the proximal (BD(Marg)) is associated with a dismal survival irrespective of whether a final negative (BD(Marg)) is achieved with an additional resection.
METHODS: Clinicopathologic, operative, and survival data of consecutive patients undergone curative intent hepatectomy with bile duct resection (n = 75) for HCC (1989-2010) were analyzed.
RESULTS: Frozen-section examination of the proximal (BD(Marg)) revealed invasive cancer in 19 of the 67 patients. After additional resection, which was possible in 18 cases, a secondary R0 (BD(Marg)) resection was achieved in 15 patients (83.3%), with 2 of these having, at final pathology, positive radial and distal margins. Eventually, 8 patients were classified as R1 and 67 as R0 (54 primary R0 and 13 secondary R0). Median survival of patients who had a secondary R0 resection (30.6 months) was similar to that of primarily R0-resected patients (29.3 months) and significantly better than that of R1 patients (14.9 months) (P = 0.026). Median time to recurrence and site of recurrence were similar in R0 patients independently of the performance of an additional resection. The incidence of biliary fistula was significantly increased (44.4% vs 17.5%; P = 0.02) in patients necessitating a margin re-resection.
CONCLUSIONS: Additional resection of a positive proximal (BD(Marg)) , albeit associated with an increased risk of biliary fistula, offers a significant survival benefit and should be attempted whenever possible.

Entities:  

Mesh:

Year:  2011        PMID: 22042470     DOI: 10.1097/SLA.0b013e3182368f85

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  32 in total

Review 1.  [Resection of Klatskin tumors].

Authors:  D Seehofer; C Kamphues; P Neuhaus
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

2.  Principles of surgical resection in hilar cholangiocarcinoma.

Authors:  Emilio Ramos
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

Review 3.  [Frozen section diagnostics in visceral surgery. Liver, bile ducts and pancreas].

Authors:  C Mogler; C Flechtenmacher; P Schirmacher; F Bergmann
Journal:  Pathologe       Date:  2012-09       Impact factor: 1.011

4.  Consensus conference on hilar cholangiocarcinoma.

Authors:  Christopher E Forsmark; Alessandro L Diniz; Andrew X Zhu
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

5.  Evaluation of positive ductal margins of biliary tract cancer in intraoperative histological examination.

Authors:  Junji Ueda; Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Masato Yoshioka; Atsushi Hirakata; Youichi Kawano; Yoshiaki Mizuguchi; Tetsuya Shimizu; Tomohiro Kanda; Hideyuki Takata; Ryota Kondo; Eiji Uchida
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

6.  Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.

Authors:  Jian Zheng; Deborah Kuk; Mithat Gönen; Vinod P Balachandran; T Peter Kingham; Peter J Allen; Michael I D'Angelica; William R Jarnagin; Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2016-12-05       Impact factor: 5.344

Review 7.  Perihilar cholangiocarcinoma: Current therapy.

Authors:  Wei Zhang; Lu-Nan Yan
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 8.  Surgical resection techniques for locally advanced hilar cholangiocarcinoma.

Authors:  Sanjay Govil; Mettu Srinivas Reddy; Mohamed Rela
Journal:  Langenbecks Arch Surg       Date:  2014-06-04       Impact factor: 3.445

Review 9.  Systematic review of perioperative and oncologic outcomes of minimally-invasive surgery for hilar cholangiocarcinoma.

Authors:  Federica Cipriani; Francesca Ratti; Guido Fiorentini; Raffaella Reineke; Luca Aldrighetti
Journal:  Updates Surg       Date:  2021-02-22

10.  Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group.

Authors:  Jean Marc Regimbeau; David Fuks; Patrick Pessaux; Philippe Bachellier; Denis Chatelain; Momar Diouf; Artigas Raventos; Georges Mantion; Jean-Francois Gigot; Laurence Chiche; Gerard Pascal; Daniel Azoulay; Alexis Laurent; Christian Letoublon; Emmanuel Boleslawski; Michel Rivoire; Jean-Yves Mabrut; Mustapha Adham; Yves-Patrice Le Treut; Jean-Robert Delpero; Francis Navarro; Ahmet Ayav; Karim Boudjema; Gennaro Nuzzo; Michel Scotte; Olivier Farges
Journal:  HPB (Oxford)       Date:  2014-07-03       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.